Joint Venture Aims to Revolutionize Wound Healing and Prevent Amputations

A groundbreaking collaboration between Lionheart Health, Inc. and ElectroMedical Technologies promises to transform wound care through advanced bioelectric healing technologies. The joint venture aims to address critical patient needs by developing innovative treatments that could potentially prevent limb amputations and improve healing outcomes for patients with complex wound conditions.

The partnership combines Lionheart Health's patented bioelectric signaling software with ElectroMed's advanced device technology platform. Their collaborative research focuses on developing comprehensive wound healing strategies that integrate multiple treatment approaches, including bioelectric stimulation, specialized protein treatments, membrane grafts, and stem cell interventions.

Preliminary pilot studies conducted in the Czech Republic, Mexico, and the United States have shown remarkable results, with over 90% of limbs previously considered for amputation being successfully saved. These promising outcomes underscore the potential impact of their joint technological approach in addressing a significant healthcare challenge.

The United States currently experiences approximately 185,000 amputations annually, predominantly related to non-healing wounds. The joint venture has set an ambitious goal of reducing this number by more than 50% within the next decade. By leveraging their combined expertise, Lionheart Health and ElectroMedical Technologies are positioning themselves at the forefront of regenerative medical technology.

Their planned clinical study will explore multiple treatment protocols, including bioelectric stimulation alone and in combination with advanced biological interventions. This comprehensive approach reflects a sophisticated understanding of wound healing mechanisms and demonstrates a commitment to developing holistic treatment strategies.

The partnership represents more than a technological collaboration; it embodies a shared vision of enhancing patient outcomes and reducing long-term healthcare costs. By developing scalable wound care solutions, the joint venture could significantly impact medical treatment approaches for patients with complex wound conditions, particularly those with diabetic ulcers.

As part of their expansion strategy, Lionheart Health is preparing to establish 124 worldwide clinics trained in their patented bioelectric treatment protocols. This global approach will help disseminate their innovative wound healing technologies and potentially transform standard wound care practices.